A dual lumen catheter may be provided with one or more stents in a stent-deployment lumen and a wire guide disposed through a wire guide lumen. The wire guide may be directed to a target site in a patient body such as a biliary stricture. The catheter may be directed along the wire guide until it is in or adjacent the target site. A distalmost stent may be advanced out a distal side-facing aperture of the stent-deployment lumen into the target site by a pusher member that advances the stent or that holds the stent in place while the catheter is proximally withdrawn from around the stent. With the wire guide remaining substantially in place, the stent-deployment lumen can be reoriented and the steps repeated to place a second (and, if desired, subsequent) stent(s) next to—and generally parallel with—the first stent.
|
1. A method of placing multiple stents side-by-side across a single stricture along an unbifurcated length of duct, the method comprising steps of:
directing only a single stent-placement catheter to a location adjacent a stricture along an unbifurcated length of duct to be stent-traversed;
directing only a single wire guide through a wire guide lumen encompassed by at least a lengthwise portion of the stent-placement catheter and through the stricture;
directing a distal end length of the stent-placement catheter through the stricture;
directing a first stent through a lengthwise stent lumen of the stent-placement catheter portion disposed within the stricture and alongside the wire guide, where first stent is advanced distally by a stent pusher and where the wire guide is unencompassed by any portion of the first stent;
moving the stent-placement catheter in a manner that leaves the first stent and the wire guide in place across the stricture; and
with the wire guide remaining disposed through the stricture and the stent-placement catheter remaining disposed within or immediately adjacent the stricture, directing a second stent through the stent lumen and through the stricture alongside the wire guide and at least partially alongside, and wholly external of, the first stent, where the second stent is advanced distally by the stent pusher and where the wire guide and the first stent are unencompassed by any portion of the second stent.
2. The method of
3. The method of
4. The method of
5. The method of
6. The method of
7. The method of
8. The method of
9. The method of
10. The method of
|
Embodiments disclosed herein generally relate to a method for placing a plurality of biliary stents across a stricture. More particularly, embodiments relate to a method and device for placing a plurality of biliary stents without requiring re-introduction of a stent delivery catheter.
Endoscopic retrograde cholangiopancreatography (ERCP) is a technique used for viewing and treating the ducts that drain the liver and pancreas. Biliary ducts form a drainage routes into the duodenum from the liver and gallbladder and they join the pancreatic duct, just before they drain into the duodenum about 3 inches from the stomach. The drainage opening is called the papilla (Ampulla of Vater). The papilla is surrounded by a circular muscle, called the sphincter of Oddi. During ERCP, X-ray contrast dye is injected into the bile duct, the pancreatic duct, or both via a catheter disposed through a working channel of an endoscope.
Two commonly used types of catheters used during ERCP procedures (particularly where a catheter may be exchanged) are referred to as “long-wire” catheters and “short-wire” catheters. A long-wire catheter is one in which a wire guide lumen is provided through the major length of the catheter. That is, in a catheter configured for use with long-wire procedures, the wire guide lumen extends through more than half, most, or all of the catheter's length. In catheters for short-wire procedures, the wire guide lumen may not extend the entire length of the catheter. In this type of catheter, the wire guide lumen may extend only from the distal end of the terminal-end device to a point intermediate the distal and proximal ends of the catheter, and often the wire guide extends through less than half or only a very small percentage of the catheter's length (defined herein as a minor length). This shorter lumen is the only portion of the catheter encompassing the wire guide during a short wire operation.
The decreased friction and the lack of a need for a wire guide that is at least about twice as long as the catheter are generally considered advantages of a short-wire catheter, although the pushability of a catheter without a wire guide engaged into a long-wire lumen may be less than that of a long-wire catheter so engaged. Short-wire catheters are often easier to exchange than catheters having the wire guide lumen extending the entire length of the catheter. This is because the wire guide need not be as long as a “long wire” configuration, which requires that a length of the wire guide extending outside the patient's body be longer than the portion of the catheter extending over the long wire guide in order for a doctor or assistant to maintain a grasp on the wire guide (to avoid undesired movement or displacement thereof). The short wire guide configuration catheters (known also as “rapid exchange catheters) also create less friction during mounting and exchange operations due to the shorter wire guide lumen, leading to a reduced likelihood of displacing the wire guide after it has been positioned, often under radiography, to a desired position/orientation.
Stents may be placed into the bile and/or pancreatic ducts to bypass strictures of the duct. These narrowed areas of the bile or pancreatic duct may be caused by—for example—inflammation, scar tissue, or tumors that cause blockage of normal duct drainage. Metal and/or plastic stents may be used, depending upon the medical indications. In some circumstances, it may be useful to provide a plurality of stents that cross a single stricture in generally parallel fashion, such as is shown—for example—in
Placement of multiple biliary stents in bile duct stricture can be technically challenging, because difficulties may arise from accessing the stricture with repeated cannulation and guide wire placement. The subsequent exchanges done over a very long guide wire may increase the procedural complexity. In the conventional manner of delivering multiple stents to traverse a single stricture, repeated bile duct cannulation and exchanges are necessary in order to place multiple stents to attain the maximum lumen diameter for the stricture. Direct cannulation with the stent preloaded on stent-delivery catheter without a prior inserted wire guide may be difficult. Although it is possible to use a single wire guide left in place to direct a first (optionally pre-loaded) stent-delivery catheter to a target site, withdraw the stent-delivery catheter, recannulate the stricture, then re-introduce the same (reloaded) or a different (preloaded) stent-delivery catheter for placement of a second stent (repeated for any subsequent stent-placement), it would be advantageous to provide a system and method for serially placing a plurality of stents that would not necessitate the time, effort, and complexity of withdrawing and reintroducing a stent-delivery catheter for second and subsequent stents targeted to traverse a single stricture or to otherwise be delivered along a single wire guide.
In one aspect, embodiments disclosed herein may include a stent-delivery catheter, as well as methods for introducing a plurality of stents therethrough to a target site in a body passage, using a novel wire-guided technique wherein the stent does not encompass the wire.
In certain embodiments, the method may allow generally parallel placement of a plurality of stents during a single procedure, which may be an ERCP procedure.
As used in the specification, the terms proximal and distal should be understood as being from the perspective of a physician operating a device embodiment and method herein for delivering a stent to a patient. Hence, the term “distal” means the portion of the delivery system that is farthest from the physician and the term “proximal” means the portion of the delivery system that is nearest to the physician. Also, as used herein unless otherwise specified, the term “end” refers to a region at and near a proximal or distal terminus, while the word “terminus” is used to refer to the absolute ends of the device defining where its construction ceases.
Embodiments are described with reference to the drawings in which like elements are generally referred to by like numerals. The relationship and functioning of the various elements of the embodiments may better be understood by reference to the following detailed description. However, embodiments are not limited to those illustrated in the drawings. It should be understood that the drawings are not necessarily to scale, and in certain instances details may have been omitted that are not necessary for an understanding of embodiments disclosed herein, such as—for example—conventional fabrication and assembly.
Various embodiments will be described more fully hereinafter. The invention is defined by the claims, may be embodied in many different forms, and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey enabling disclosure to those skilled in the art. As used in this specification and the claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Visualization of this procedure may be done using radiography and/or ultrasound, as stent construction materials, catheter construction materials, and operating procedures needed for effecting the presently disclosed method are within the skill of those in the relevant art. The method and device embodiments described herein may be used via an endoscope such as—for example—a transesophageal endoscope, percutaneously (via a laparoscope, associated trocar, or other percutaneous access device), in some combination thereof, or via other means, with preferable use being with minimally invasive surgical methods and devices.
Embodiments of a device and method for placement of multiple stents (e.g., plastic biliary stents) are described here with reference to
In
Deployment of a second stent 232 is described with reference to
In the same manner as was used to deploy the first stent 230, and as shown in
Those of skill in the art will appreciate that embodiments not expressly illustrated herein may be practiced within the scope of the claims, including that features described herein for different embodiments may be combined with each other and/or with currently-known or future-developed technologies while remaining within the scope of the claims presented here. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation. It is therefore intended that the foregoing detailed description be regarded as illustrative rather than limiting. And, it should be understood that the following claims, including all equivalents, are intended to define the spirit and scope of this invention. Furthermore, the advantages described above are not necessarily the only advantages of the invention, and it is not necessarily expected that all of the described advantages will be achieved with every embodiment of the invention.
Devereux, Paul, Toomey, Ciarán, White, Sharon
Patent | Priority | Assignee | Title |
11154411, | Dec 22 2015 | ENDO GI MEDICAL LTD | Deployment of multiple biliary stents |
11382776, | Jul 29 2018 | BVW Holding AG | Biliary stent |
11744694, | Jan 01 2020 | ENDO GI MEDICAL LTD | Methods and assemblies for deploying biliary stents |
Patent | Priority | Assignee | Title |
5669924, | Oct 26 1995 | Y-shuttle stent assembly for bifurcating vessels and method of using the same | |
7229472, | Nov 16 2000 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Thoracic aneurysm repair prosthesis and system |
20040220664, | |||
20050125050, | |||
20060142704, | |||
20080033521, | |||
20120016454, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 19 2012 | Cook Medical Technologies LLC | (assignment on the face of the patent) | / | |||
Sep 07 2012 | TOOMEY, CIARAN | Cook Ireland Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029130 | /0068 | |
Sep 07 2012 | WHITE, SHARON | Cook Ireland Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029130 | /0068 | |
Sep 25 2012 | DEVEREUX, PAUL | Cook Ireland Limited | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029130 | /0068 | |
Oct 08 2012 | Cook Ireland Limited | Cook Medical Technologies LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029130 | /0188 | |
Feb 27 2024 | Cook Medical Technologies LLC | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 066700 | /0277 |
Date | Maintenance Fee Events |
Jul 16 2018 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Jul 13 2022 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Feb 17 2018 | 4 years fee payment window open |
Aug 17 2018 | 6 months grace period start (w surcharge) |
Feb 17 2019 | patent expiry (for year 4) |
Feb 17 2021 | 2 years to revive unintentionally abandoned end. (for year 4) |
Feb 17 2022 | 8 years fee payment window open |
Aug 17 2022 | 6 months grace period start (w surcharge) |
Feb 17 2023 | patent expiry (for year 8) |
Feb 17 2025 | 2 years to revive unintentionally abandoned end. (for year 8) |
Feb 17 2026 | 12 years fee payment window open |
Aug 17 2026 | 6 months grace period start (w surcharge) |
Feb 17 2027 | patent expiry (for year 12) |
Feb 17 2029 | 2 years to revive unintentionally abandoned end. (for year 12) |